Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions
dc.rights.license | open | en_US |
dc.contributor.author | BRACKEN, Sonali J. | |
dc.contributor.author | SUTHERS, Amy N. | |
dc.contributor.author | DICIOCCIO, Rachel A. | |
dc.contributor.author | SU, Hsuan | |
dc.contributor.author | ANAND, Sarah | |
dc.contributor.author | POE, Jonathan C. | |
dc.contributor.author | JIA, Wei | |
hal.structure.identifier | Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept] | |
dc.contributor.author | VISENTIN, Jonathan | |
dc.contributor.author | BASHER, Fahmin | |
dc.contributor.author | JORDAN, Collin Z. | |
dc.contributor.author | MCMANIGLE, William C. | |
dc.contributor.author | LI, Zhiguo | |
dc.contributor.author | HAKIM, Frances T. | |
dc.contributor.author | PAVLETIC, Steven Z. | |
dc.contributor.author | BHUIYA, Nazmim S. | |
dc.contributor.author | HO, Vincent T. | |
dc.contributor.author | HORWITZ, Mitchell E. | |
dc.contributor.author | CHAO, Nelson J. | |
dc.contributor.author | SARANTOPOULOS, Stefanie | |
dc.date.accessioned | 2025-02-03T08:31:19Z | |
dc.date.available | 2025-02-03T08:31:19Z | |
dc.date.issued | 2024-01 | |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/204696 | |
dc.description.abstractEn | Chronic graft-versus-host disease (cGVHD) is a debilitating, autoimmune-like syndrome that can occur after allogeneic hematopoietic stem cell transplantation. Constitutively activated B cells contribute to ongoing alloreactivity and autoreactivity in patients with cGVHD. Excessive tissue damage that occurs after transplantation exposes B cells to nucleic acids in the extracellular environment. Recognition of endogenous nucleic acids within B cells can promote pathogenic B-cell activation. Therefore, we hypothesized that cGVHD B cells aberrantly signal through RNA and DNA sensors such as Toll-like receptor 7 (TLR7) and TLR9. We found that B cells from patients and mice with cGVHD had higher expression of TLR7 than non-cGVHD B cells. Using ex vivo assays, we found that B cells from patients with cGVHD also demonstrated increased interleukin-6 production after TLR7 stimulation with R848. Low-dose B-cell receptor (BCR) stimulation augmented B-cell responses to TLR7 activation. TLR7 hyperresponsiveness in cGVHD B cells correlated with increased expression and activation of the downstream transcription factor interferon regulatory factor 5. Because RNA-containing immune complexes can activate B cells through TLR7, we used a protein microarray to identify RNA-containing antigen targets of potential pathological relevance in cGVHD. We found that many of the unique targets of active cGVHD immunoglobulin G (IgG) were nucleic acid–binding proteins. This unbiased assay identified the autoantigen and known cGVHD target Ro-52, and we found that RNA was required for IgG binding to Ro-52. Herein, we find that BCR-activated B cells have aberrant TLR7 signaling responses that promote potential effector responses in cGVHD. | |
dc.language.iso | EN | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.title.en | Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions | |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1182/bloodadvances.2023010362 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Immunologie | en_US |
dc.identifier.pubmed | 38113462 | en_US |
bordeaux.journal | BLOOD ADVANCES | en_US |
bordeaux.page | 667 – 680 | en_US |
bordeaux.volume | 8 | en_US |
bordeaux.hal.laboratories | ImmunoConcEpT - UMR 5164 | en_US |
bordeaux.issue | 3 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.institution | CNRS | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
hal.identifier | hal-04925991 | |
hal.version | 1 | |
hal.date.transferred | 2025-02-03T08:31:23Z | |
hal.popular | non | en_US |
hal.audience | Internationale | en_US |
hal.export | true | |
dc.rights.cc | CC BY-NC-ND | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BLOOD%20ADVANCES&rft.date=2024-01&rft.volume=8&rft.issue=3&rft.spage=667%20%E2%80%93%20680&rft.epage=667%20%E2%80%93%20680&rft.au=BRACKEN,%20Sonali%20J.&SUTHERS,%20Amy%20N.&DICIOCCIO,%20Rachel%20A.&SU,%20Hsuan&ANAND,%20Sarah&rft.genre=article |
Fichier(s) constituant ce document
Fichiers | Taille | Format | Vue |
---|---|---|---|
Il n'y a pas de fichiers associés à ce document. |